Viewing nowCombinationRosuvastatin/Ezetimibe Tablets 10/5 milligrams
Rosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 202004602 · Approved 2020.06.23 · Insurance code 650304200
For the treatment of primary hypercholesterolemia and mixed dyslipidemia
This medication helps lower total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, particularly familial and non-familial types, or mixed dyslipidemia, while increasing HDL cholesterol levels. It is used primarily as an adjunct to dietary therapy and is administered when dietary modification alone, aimed at limiting saturated fat and cholesterol intake, is insufficient. Additionally, when using lipid-lowering drugs in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, other risk factors should be considered. Prior to treatment, secondary causes of dyslipidemia such as diabetes, hypothyroidism, liver disease, and renal failure should be identified and treated if necessary. Lipid levels, including total cholesterol, LDL, HDL, and triglycerides, should be monitored regularly; especially when triglycerides are high, ultracentrifugation methods should be used for accurate measurement. This medication is utilized to improve dyslipidemia and reduce the risk of atherosclerotic disease.
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause muscle disorders such as myopathy or, rarely, serious muscle injury called rhabdomyolysis, so if symptoms such as muscle pain or weakness occur, medical consultation should be sought immediately. In cases with risk factors for muscle injury, such as severe infections, hypotension, major surgery or trauma, metabolic disorders, or uncontrolled seizures, the use of this medication may need to be temporarily or permanently discontinued. Patients with hypersensitivity to this medication or those with active liver disease, muscle disorders, or severe renal impairment should not take this drug. Women who are pregnant or may become pregnant, as well as nursing mothers, should also avoid using this medication. Patients with a high risk of muscle injury, such as alcoholics, patients with poor liver function, elderly individuals, and hypothyroid patients, should use this medication with caution. Furthermore, co-administration of certain specific medications can increase the risk of muscle injury, so any ongoing medications should be reported to a doctor or pharmacist. This medication can burden the liver, and periodic liver function tests should be conducted before and during treatment. If blood tests show elevated levels of the muscle damage marker CPK, the use of this medication may need to be suspended. During treatment with this medication, symptoms such as dizziness, headache, indigestion, muscle pain, edema may occur; if symptoms are severe, consultation with healthcare professionals is advised. This medication contains lactose, so patients with lactose intolerance should be cautious. Dizziness may occur during driving or operating machinery; therefore caution is needed. Extra care is required when administering to children or the elderly, and safety in pediatric patients has not been sufficiently established. In case of overdose, there is no specific antidote, so treatment based on symptoms along with liver and muscle function tests is necessary. This medication must be kept out of the reach of children and should not be transferred to another container.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory tract infection, elevated blood sugar, increased serum CPK, chest discomfort, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, fatigue, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory decline, forgetfulness, amnesia, memory impairment, confusion, severe myasthenia, ocular myasthenia, dizziness, fatigue, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, dry mouth, discomfort in the epigastric region, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, low back pain, increased serum creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, the storage temperature should be kept between 1 and 30 degrees Celsius at room temperature, avoiding excessively hot or cold places.
Pink rectangular film-coated tablet
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.